Publication Venue For
- Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung 2022
- The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study 2019
- Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study 2018
- Detection of EGFR and KRAS mutations in circulating free DNA in patients with operable non small cell lung cancer (NSCLC) 2009
- 221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma 2006
- O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study 2005
- E-53. Helical tomotherapy: An innovative technological radiation therapeutic approach for lung cancer 2003
- P-602 Concurrent end-phase boost radiation therapy to 65 Gy in 5 weeks for non-small cell lung cancer with or without cisplatin chemotherapy 2003
- Phase II study of Exatecan Mesylate (DX-8951f) in advanced NSCLC 2000